Synonyms: Example A26 [WO2023060253A1] | RMC9805
Compound class:
Synthetic organic
Comment: RMC-9805 is an orally active KRASG12D(ON) inhibitor. Like its predecessor, elironrasib, RMC-9805 acts a molecular glue to promote the formation of a tricomplex between the ligand, target and cyclophilin A, to ultimately block oncogenic RAS signalling and induce tumour cell apoptosis. It was designed for potential to treat KRASG12D-mutated solid tumours. RMC-9805 is one of the RAS inhibitors claimed in Revolution Medicines' patent WO2023060253A1 [1].
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Synonyms ![]() |
Example A26 [WO2023060253A1] | RMC9805 |
Database Links ![]() |
|
CAS Registry No. | 2922732-54-3 (source: PubChem) |
GtoPdb PubChem SID | 500839892 |
PubChem CID | 168201327 |
Search Google for chemical match using the InChIKey | VKNNQJWNUPSOEK-VCAAAJMFSA-N |
Search Google for chemicals with the same backbone | VKNNQJWNUPSOEK |
UniChem Compound Search for chemical match using the InChIKey | VKNNQJWNUPSOEK-VCAAAJMFSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | VKNNQJWNUPSOEK-VCAAAJMFSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
RMC-9805 (links to external site)
Cat. No. HY-156819 |